A Day Up For Pliant Therapeutics Inc.
Mon, Jul 11, 2022 at 08:33 PM
Pliant Therapeutics Inc. (PLRX:NASDAQ) jumped higher at $23, representing a gain of 159%. On Mon, Jul 11, 2022, PLRX:NASDAQ touched a New 2-Week High of $23. The stock appeared on our News Catalysts scanner on Mon, Jul 11, 2022 at 07:29 PM in the 'BIOTECH' category. From Mon, Jun 27, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days
About Pliant Therapeutics Inc. (PLRX:NASDAQ)
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.
Top 10 Gainers:
- Kaspien Holdings Inc. (KSPN:NASDAQ), 161.92%
- Pliant Therapeutics Inc. (PLRX:NASDAQ), 159.01%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 81.12%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Iterum Therapeutics plc (ITRM:NASDAQ), 40.42%
- Volcon Inc. (VLCN:NASDAQ), 40%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 34.38%
- SQL Technologies Corp. (SKYX:NASDAQ), 32.56%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 27.23%
- Kalera Public Limited Company (KAL:NASDAQ), 20.35%